M&A/IPOs

 

Circle divests to get BMI deal through

UK private hospital operator Circle Health is to divest its Bath and Birmingham hospitals to get competition watchdog approval for its buyout of larger competitor BMI Healthcare.

CVC acquisition ‘would trigger rush of M&A in Greece’

CVC Capital Partners clearly has big plans in Greece. After a slew of acquisitions, it looks poised to up its bid for Ethniki Insurance now that the process has opened up again. HBI talks to a market expert to find out more about a deal which he thinks trigger a wave of activity.

Bergman set to enter German ophthalmology market

HBI hears that Dutch and Nordic ambulatory and ophthalmology clinic chain Bergman Clinic is looking to acquire two substantial outpatient ophthalmology chains in Germany. This would mark its entry into the country’s ophthalmology market – and a significant one at that. We talk to a source about the targets, the price, and what this means for the wider market. Longer-term Bergman itself is likely to sell.

Could Synlab’s UK success open the outsourcing floodgates?

UK lab group Viapath has been nationalised, after Guy's and St Thomas' and King's College Hospital NHS Foundation Trusts bought out its private sector partner Serco following the loss of a £2.25bn outsourcing contract in which Synlab remains the preferred bidder. Could Synlab's expected success be the first of a slew of new outsourcing contracts for big lab platforms? HBI talks to a consultant to find out more.

Asklepios set to win control of Rhoen

Asklepios has effectively taken over Rhoen Klinikum after B Braun with a 25% stake accepted the offer. The deal increases the consolidation in the private hospital sector.

€300m-plus IPO for Middle East’s largest imaging platform planned

Africa-focused private equity firm Meditterania Capital Partners intends to triple the EBITDA of its recently-formed imaging platform Ray Lab which spans Egypt, Jordan and Saudi Arabia before exiting, preferably by IPO, in a few years' time, partner Daniel Viñas tells HBI. He discusses the specifics of the deal, merging Ray Lab's two businesses, and how its markets are evolving.

French radiology investment shows route into market

Private equity firm UI Gestion's investment in a Parisian radiology practice last year was uniquely structured and shows how to enter the highly fragmented French radiology sector, HBI is told.

CVC bumps up offer price for HCG

PE firm CVC has increased its offer for Indian oncology chain HCG in anticipation of a rival bid from another of the cancer chain's large shareholders, Temasek. 

PATRIZIA deal suggests healthcare real estate remains resilient, despite COVID

Global real-estate investor PATRIZIA AG has acquired a portfolio of seven healthcare assets in Germany specialising in assisted living and specialist care in a sale & leaseback deal. Is this a good time to be investing in this sector in the light of the coronavirus pandemic? How is it affecting prices? HBI looks further at the deal and speaks to a consultant to find out more.

Find Us